(2019) Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials. Journal of Controlled Release. pp. 116-137.
Text
1-s2.0-S0168365919306091-main.pdf Download (2MB) |
Abstract
According to WHO (World Health Organization) reports, more than 770,000 people died from HIV and almost 1.7 million people becoming newly infected in the worldwide in 2018. Therefore, many attempts should be done to produce a forceful vaccine to control the AIDS. DNA-based vaccines have been investigated for HIV vaccination by researches during the recent 20 years. The DNA vaccines are novel approach for induction of both type of immune responses (cellular and humoral) in the host cells and have many advantages including high stability, fast and easy of fabrication and absence of severe side effects when compared with other vaccination methods. Recent studies have been focused on vaccine design, immune responses and on the use of adjuvants as a promising strategy for increased level of responses, delivery approaches by viral and non-viral methods and vector design for different antigens of HIV virus. In this review, we outlined the aforementioned advances on HIV DNA vaccines. Then we described the future trends in clinical trials as a strong strategy even in healthy volunteers and the potential developments in control and prevention of HIV. © 2019 Elsevier B.V.
Item Type: | Article |
---|---|
Keywords: | Clinical trials; DNA vaccine; HIV; Immune responses; Vaccine design |
Page Range: | pp. 116-137 |
Journal or Publication Title: | Journal of Controlled Release |
Journal Index: | Pubmed, Scopus |
Volume: | 316 |
Identification Number: | https://doi.org/10.1016/j.jconrel.2019.10.045 |
Depositing User: | پریسا مرادی |
URI: | http://eprints.thums.ac.ir/id/eprint/1522 |
Actions (login required)
View Item |